In the eukaryotic cell cycle, the G2-M transition is regulated by a counteracting kinase/phosphatase mechanism. A novel player, Tome-1, has now been found to trigger entry into mitosis by interfering with this kinase/phosphatase 'switch'.
Cell-cycle transitions are regulated by the interplay between cyclin-dependent kinases (Cdks) and ubiquitin-mediated proteolysis. The anaphasepromoting complex (APC) and the Skp1-cullin-F box protein (SCF) complex are two related ubiquitin ligases which regulate cell-cycle progression by targeting cyclins and cyclin-dependent kinase inhibitors, respectively, for proteasomal degradation [1, 2] . Both of these ubiquitin ligases are themselves regulated by phosphorylation in a way that allows the APC to be active during mitosis and G1, whereas the SCF ubiquitinates most of its substrates from the G1-S transition until early mitosis.
Entry into mitosis requires activation of Cdk1. For this to occur, inhibitory phosphates on Cdk1 must be removed by the phosphatase Cdc25. Proper timing is assured by the opposing effect of the kinase Wee1, building a switch-like mechanism for Cdk1 activation [3,4]. Various regulatory mechanisms converge on this kinase/phosphatase switch, shifting the balance towards Cdc25 for mitotic entry or towards Wee1 to keep the cell in G2 (Figure 1) [5]. For example, Wee1 itself is negatively regulated by phosphorylation and degraded in an SCF-dependent manner. Ayad et al.
[6] have now identified a novel factor, Tome-1, the depletion of which from Xenopus egg extracts prevents mitotic entry. The authors show that Tome-1 regulates Cdk1 activation by targeting Wee1 for degradation, shifting the Cdc25/Wee1 balance towards the phosphatase and activation of Cdk1. Furthermore they find that, in somatic cells, Tome-1 is degraded in G1 in an APC-dependent manner.
Tome-1 was identified by screening pools of in vitro translated Xenopus laevis cDNAs for novel G1 substrates of the APC. APC activity is regulated during the cell cycle by its association with two regulatory proteins, Cdc20 and Cdh1 Current Biology
